Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at ...
Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma Two abstracts featuring new Phase 2 data highlight the potential of CAR ...
He apologetically explains that he’s been charged with enhancing his new vampire movie with a pair of fictional Transylvanian ...
A team of high school journalists on what's working — and what isn't — with Oregon's new ban on cell phones in schools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results